1. Department of Pharmaceutics, Uppsala Biomedical Center, Uppsala University, P.O. Box 580, SE-751 23 Uppsala, Sweden; Department of Medicinal Chemistry, AstraZeneca Research and Development, SE-151 85 Södertälje, Sweden; and Department of Medicinal Chemistry, Institute of Pharmacy, University of Tromsø, N-9037 Tromsø, Norway